...
首页> 外文期刊>SOJ Biochemistry >Differential Antimicrobial Effectiveness of Camel Lactoferrin-Oleic Acid and Bovine Lactoferrin-Oleic Acid Complexes against Several Pathogens
【24h】

Differential Antimicrobial Effectiveness of Camel Lactoferrin-Oleic Acid and Bovine Lactoferrin-Oleic Acid Complexes against Several Pathogens

机译:骆驼乳铁蛋白-油酸复合物和牛乳铁蛋白-油酸复合物对几种病原菌的差异抗菌作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Considering the superior biological activities of Camel Lactoferrin (cLf) over lactoferrin from other animal species; which we previously confirmed and continuing the analysis of antimicrobial effectiveness of cLf; we started in previous studies, the current study aimed to formulate a protein-fatty acid complex of cLf and Oleic Acid (OA) and to compare it’s in vitro antimicrobial activities against different pathogens with those of a similar Bovine Lactoferrin (bLf)-OA complex. Antimicrobial activity of these complexes was evaluated by agar disc diffusion method, broth microdilution assay, and ELISAestimating Lf and its complexes binding to bacterial outer membrane proteins. Agar disc diffusion assay results revealed that inhibitory activity of both free cLf and cLf-OA against 13 test pathogens (Methicillin-Resistant Staphylococcus Aureus (MRSA), Staphylococcus aureus, Bacillus cereus, Escherichia coli, Salmonella typhi, Shigella sonnei, Klebsiella pneumonia, Pseudomonas aeruginosa, Proteus vulgaris, Serratia marcescens, Candida albicans, Aspergillus niger, and Aspergillus flavus) noticeably exceeded that of corresponding bLf and bLf-OA. Additionally, free OA exhibited antimicrobial activity against MRSA, S. aureus, B. cereus, and C. albicans and to a lesser extent against E. coli, K. pneumonia as well as A. niger and A. flavus. Consequently, synergy was evident between cLf/bLf and OA (mostly higher in case of cLf) in prepared complexes against MRSA, S. aureus, B. cereus, and C. albicans. cLf-OA demonstrated 4 times lower Minimum Inhibitory Concentration (MIC) values against MRSA, B. cereus, and C. albicans than bLf-OA; indicating more superiority in case of cLf-OA than free cLf that showed only twice the activity of bLf. ELISA signals confirmed binding of biotinylated cLf/bLf and cLf/bLf-OA to bacterial membrane proteins. This study proves that cLf obtains enhanced antimicrobial activities after complex formation with fatty acids such as OA even than its free form which has already superior activity than other Lf species; thus this complex may be used as a cure of various microbial infections.
机译:考虑到骆驼乳铁蛋白(cLf)优于其他动物物种的乳铁蛋白的生物活性;我们先前已经确认并继续分析cLf的抗菌效果;我们从先前的研究中开始,当前的研究旨在配制cLf和油酸(OA)的蛋白质-脂肪酸复合物,并将其对不同病原体的体外抗菌活性与类似的牛乳铁蛋白(bLf)-OA复合物的抗菌活性进行比较。通过琼脂圆盘扩散法,肉汤微稀释测定和ELISA估计Lf及其复合物与细菌外膜蛋白的结合,评估了这些复合物的抗菌活性。琼脂圆盘扩散测定结果表明,游离cLf和cLf-OA均对13种测试病原体(耐甲氧西林金黄色葡萄球菌(MRSA),金黄色葡萄球菌,蜡状芽孢杆菌,大肠杆菌,鼠伤寒沙门氏菌,志贺氏菌,松藻,克雷伯氏菌)具有抑制活性铜绿假单胞菌,寻常变形杆菌,粘质沙雷氏菌,白色念珠菌,黑曲霉和黄曲霉)明显超过了相应的bLf和bLf-OA。另外,游离OA对MRSA,金黄色葡萄球菌,蜡状芽孢杆菌和白色念珠菌具有抗微生物活性,在较小程度上对大肠杆菌,肺炎克雷伯氏菌以及黑曲霉和黄曲霉具有抗微生物活性。因此,在制备的针对MRSA,金黄色葡萄球菌,蜡状芽孢杆菌和白色念珠菌的复合物中,cLf / bLf和OA之间的协同作用明显(在cLf情况下更高)。 cLf-OA的抗MRSA,蜡状芽孢杆菌和白色念珠菌的最低抑菌浓度(MIC)值比bLf-OA低4倍;表明在cLf-OA的情况下比仅显示bLf活性两倍的游离cLf优越。 ELISA信号证实了生物素化的cLf / bLf和cLf / bLf-OA与细菌膜蛋白的结合。这项研究证明,与脂肪酸(如OA)形成复合物后,cLf的抗微生物活性增强,甚至比其游离形式(其活性已优于其他Lf物种)的游离形式也增强。因此,该复合物可用于治愈各种微生物感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号